Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,901 | -5,978 | -23,283 | -16,584 | -9,747 |
| Depreciation Amortization | 552 | 272 | 1,031 | 749 | 489 |
| Accounts payable and accrued liabilities | -441 | 414 | 588 | 312 | 101 |
| Other Working Capital | -1,304 | -601 | 1,535 | 152 | 1,586 |
| Other Operating Activity | 3,207 | 1,137 | 4,906 | 4,106 | 2,056 |
| Operating Cash Flow | $-9,887 | $-4,756 | $-15,223 | $-11,266 | $-5,516 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -231 | 3,506 | 17,030 | 16,938 | 16,471 |
| PPE Investments | -600 | -545 | -260 | -224 | N/A |
| Investing Cash Flow | $-831 | $2,961 | $16,770 | $16,713 | $16,471 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -12 | -6 | -30 | -25 | -16 |
| Common Stock Issued | 99 | 99 | 6,995 | 6,981 | 6,981 |
| Financing Cash Flow | $87 | $93 | $6,965 | $6,957 | $6,965 |
| Beginning Cash Position | 21,280 | 21,280 | 12,768 | 12,769 | 12,769 |
| End Cash Position | 10,649 | 19,578 | 21,280 | 25,173 | 30,688 |
| Net Cash Flow | $-10,631 | $-1,702 | $8,512 | $12,404 | $17,920 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,887 | -4,756 | -15,223 | -11,266 | -5,516 |
| Capital Expenditure | -600 | -545 | -260 | -224 | N/A |
| Free Cash Flow | -10,487 | -5,301 | -15,483 | -11,490 | -5,516 |